Delivery Order SPE2DB22D1202-SPE2DB25FUHK9

Award Date 11/4/24
Potential Completion Date 11/5/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,944.30, is for the delivery of Lamotrigine ODT 100 mg tablets. This is a delivery order contract with a firm-fixed price pricing type. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,314.17 contract is for the supply of 30-count tablets of the generic medication lamotrigine orally disintegrating tablets (ODT) in 25 milligram strength. The delivery order has a performance period through March 27, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,156.56 firm fixed-price contract is for the supply of Lamotrigine ODT 200 mg tablets, a prescription medication, to support military treatment programs and facilities. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LAMOTRIGINE ODT 50 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,699.22 and a period of performance through June 26, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LAMOTRIGINE ODT 100 MG TABLET 30S medication, with a ceiling value of $2,945.58 and an ultimate completion date of June 18, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,401.79, is for the delivery of Lamotrigine ODT 100 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing model. The contract has a period of performance through November 7, 2024 and was awarded on November 6, 2024. There was no set-aside designation for this...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lamotrigine ODT 50 mg tablets, a medication used to treat certain types of seizures. The contract has a ceiling value of $20,267.48 and is a firm fixed-price, non-set-aside contract with a period of performance through May 9, 2025. AmerisourceBergen holds a significant Indefinite...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Lamotrigine ODT 50 mg Tablets in 30-count bottles, with a total ceiling value of $1,889.85 and a period of performance through May 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $1,027.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LAMOTRIGINE ODT 25 MG TABLET 30S, a pharmaceutical product, with a completion date of July 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a $1,059.78 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lamotrigine ODT 200 mg tablets, a neurological medication, with a performance period through June 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is a critical supplier of pharmaceutical...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUHK9
    Delivery Order

The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4566320992 units of Lamotrigine ODT 100 mg Tablets. The contract has a ceiling value of $1,564.64 and will run through November 5, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC covers a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not indicate the use of any set-aside requirements, suggesting open competition.

Generated 2/3/25, 1:43 PM